A novel approach for modifying tumor cell-derived plasma membrane vesicles to contain encapsulated IL-2 and engrafted costimulatory molecules for use in tumor immunotherapy. [electronic resource]
Producer: 20020307Description: 63-72 p. digitalISSN:- 0020-7136
- Animals
- B7-1 Antigen -- administration & dosage
- CD40 Antigens -- administration & dosage
- Cancer Vaccines -- immunology
- Cell Adhesion
- Cell Membrane -- metabolism
- Cell Survival
- Female
- Immunization
- Interleukin-2 -- administration & dosage
- Lymphocyte Activation
- Male
- Mice
- Mice, Inbred BALB C
- Mice, Inbred DBA
- Recombinant Proteins -- administration & dosage
- T-Lymphocytes -- immunology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.